🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06183541
Recruiting Not applicable

Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.

NCT06183541 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2023-11-21
Last updated
2025-11-19

Condition(s) studied

Hip FracturesPain, Postoperative

Investigational drug(s) / intervention(s)

Pericapsular Nerve Group (PENG) Block

Pericapsular Nerve Group (PENG) Block: Pericapsular nerve group (PENG) block The femoral nerve and obturator nerve terminal branches, which provide sensory innervation of the hip joint, are blocked, thus providing analgesia without creating a motor block.

Study summary

In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated.

Postoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.

Eligibility

Sex
ALL
Min age
30 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who will undergo hip fracture surgery Women and men aged 30-85 Exclusion Criteria: * Patients under 30 years old, over 85 years old * American Society of Anesthesiology (ASA) IV, * Those with cognitive impairment (alzheimer, dementia, delirium, etc.) * Those with application site infection * Those who are allergic to local anesthetic substances * Patients are non-consenting patients.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Umraniye Education and Research Hospital Istanbul Umraniye Recruiting
UmraniyeERH Istanbul Umraniye Recruiting

More Umraniye Education and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06183541 on ClinicalTrials.gov ↗ ← All trials in Turkey